Stephan Schmidt

Gesundheitszentrum St. Johannes Hospital
Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Digital lifestyle management application (levidex) for empowerment and health behaviour change in early multiple sclerosis - Results of the randomised controlled POWER@MS1 trial.

Digital lifestyle management application (levidex) for empowerment and health behaviour change in early multiple sclerosis - Results of the randomised controlled POWER@MS1 trial.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 12, 2025

Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis - initial results from the observational SISTER study.

Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis - initial results from the observational SISTER study.

Journal: Therapeutic advances in neurological disorders

Published: November 23, 2023

Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?

Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?

Journal: International journal of molecular sciences

Published: November 24, 2022

Experiences of persons with multiple sclerosis with rehabilitation-a qualitative interview study.

Experiences of persons with multiple sclerosis with rehabilitation-a qualitative interview study.

Journal: BMC health services research

Published: November 09, 2021

Development and evaluation of a website with patients experiences of multiple sclerosis: a mixed methods study.

Development and evaluation of a website with patients experiences of multiple sclerosis: a mixed methods study.

Journal: BMC neurology

Published: August 25, 2021

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany.

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany.

Journal: Journal of neurology

Published: August 16, 2021

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

Journal: Therapeutic advances in neurological disorders

Published: May 27, 2021

Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)

Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)

Journal: Der Nervenarzt

Published: May 07, 2021

Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice.

Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice.

Journal: Multiple sclerosis and related disorders

Published: May 07, 2021

Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.

Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.

Journal: PloS one

Published: April 02, 2021

Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.

Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.

Journal: Brain : a journal of neurology

Published: March 08, 2021

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients.

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients.

Journal: Frontiers in neurology

Published: December 02, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026